Provision of Business Intelligence Software for Medicines Optimisation

NHS North East London (Part of North East London Health and Care Partnership) is seeking expressions of interest from organisations who are established providers of a Business Intelligence Software for Medicines Optimisation which can help ICS's/ Alliances / PCNs / Clusters and GP Practices to simplify its Medicines Optimisation QIPP project work. The use of the software is to allow clinical professionals to record their patient review outcomes, documenting drug costs/savings, review risk of hospital admissions, request lab tests, all through the use of enhanced reporting tools and savings generating algorithms.

The system is unique as it provides reports and dashboards using NHS data, creates benchmarking comparisons within NEL areas and enables patient review outcomes to be stored on it's platform.

NHS NEL currently has a GP registered population of over 2 million patients served by 276 GP practices organised into 49 Primary Care Networks (PCNs) across seven local authorities and the Corporation of the City of London with five NHS provider Trusts (3 Acute and 2 Mental Health Trusts).

For the delivery of the business intelligence software for medicines optimisation, the provider is required to deliver

NHS North East London ICB currently procures this service from a company called MedOptimise Ltd and it provides access to prescribing resources online via a platform which includes prescribing analysis, cost savings data and dashboards to ensure that treatments prescribed to patients are safe, effective and good value for money. This makes the platform and service offering unique and an efficient resource for recording and evaluating the impact of medication reviews and other QIPP related workstreams.

The MedOptimise service has been procured through an annual licence arrangement.

MedOptimise has been in use in North East London for at least 2 years. MedOptimise is unique in the way it provides specialist expertise needed to support medicine optimisation across North East London through its unique provision of data analysis reports, dashboards, ability to record interventions and clinical decision support.

NHS North East London believes that MedOptimise Ltd is the only supplier of these services in England and based on that belief intends to directly award a contract to MedOptimise Ltd for a continuation of the services. This award will be using a Regulation 32 PCR negotiated procedure without prior publication.

The aannual value of the contract is £34,950 per annum (£174,750 for 5 years contract).

Interested organisations must express an interest and submit the completed EOI form to

nelondonicb.contracting@nhs.net

Please note that any expressions of interests by any other means will not be considered.

Additional information: Organisations expressing an interest should provide a detailed description of:

Organisations interested in providing this service will be required to comply with the following:

MedOptimise has been a continuous supplier in North East London for at least 2 years and the ICB is confident that service delivery over a 5 year period can be maintained.

The MedOptimise licence arrangement is renewed on an annual basis.

The planned contract will commence on 1st April 2023 and run for a five year contract term expiring on 31st March 2028.

Interested organisations must express an interest and submit the completed EOI form to

nelondonicb.contracting@nhs.net

Please note that any expressions of interests by any other means will not be considered.